Retatrutide 10mg Vial

Retatrutide 10mg is an investigational peptide supplied in a lyophilized (freeze-dried) sterile vial formulation intended for controlled laboratory or research use only. It is a long-acting triple receptor agonist that targets GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors, which are pathways involved in metabolic regulation and energy balance.

Each vial contains 10mg of Retatrutide in powder form and is typically reconstituted with a sterile diluent before use in research settings. Due to its extended half-life (approximately one week in studied models), it is commonly evaluated in once-weekly experimental protocols.

Retatrutide is currently an investigational compound and is not approved for therapeutic use, prescription use, or human consumption outside clinical trials. All handling should comply with applicable research regulations and laboratory safety standards.